7-64522133-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178558.5(ZNF680):c.621G>T(p.Glu207Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000482 in 1,611,584 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178558.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000394 AC: 60AN: 152102Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000333 AC: 83AN: 249284Hom.: 0 AF XY: 0.000356 AC XY: 48AN XY: 134730
GnomAD4 exome AF: 0.000491 AC: 717AN: 1459364Hom.: 1 Cov.: 34 AF XY: 0.000468 AC XY: 340AN XY: 725746
GnomAD4 genome AF: 0.000394 AC: 60AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.000322 AC XY: 24AN XY: 74436
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2023 | The c.621G>T (p.E207D) alteration is located in exon 4 (coding exon 4) of the ZNF680 gene. This alteration results from a G to T substitution at nucleotide position 621, causing the glutamic acid (E) at amino acid position 207 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at